BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
BPI Events
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
Recent in
Upstream
See all
turbulent flow image
Bioreactors
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
by
Muhammad Arshad Chaudhry
Jun 12, 2024
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
Recent in
Downstream
See all
Thermo Fisher/AstraZeneca webinar title slide
Chromatography
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
by
BPI Contributor
Jun 6, 2024
30 Min View
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
eBook cover
Fill/Finish
eBook: Drug Delivery — New Formats for Novel Biopharmaceuticals
eBook: Drug Delivery — New Formats for Novel Biopharmaceuticals
by
Cheryl Scott,
Vincenza Pironti
and 2 more
Jun 26, 2024
buffer design workflow
Information Technology
Buffer Design for Biopharmaceutical Processes: An Online Tool for Designing and Understanding Buffers
Buffer Design for Biopharmaceutical Processes: An Online Tool for Designing and Understanding Buffers
by
Natraj Ram ,
Adharsh Ravi
Jun 19, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
hand cleaning equipment
QA/QC
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
by
Ram Kouda,
Syeda Tabassum
and 3 more
Jun 12, 2024
scientists looking through microscope
QA/QC
Establishing a Life Cycle for Relaundered Cleanroom Garments
Establishing a Life Cycle for Relaundered Cleanroom Garments
by
Tim Sandle
Jun 12, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
Resilience logo
Sponsored Content
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
by
BPI Contributor
Jun 25, 2024
15 Min View
scientist at computer
Bioregions
US–India Collaborative Innovations for Rapid Drug Discovery
US–India Collaborative Innovations for Rapid Drug Discovery
by
Jitendra Kumar
Jun 12, 2024
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
iStock photo
Cell Therapies
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
by
Brent Morse,
Alicja Fiedorowicz
Jun 19, 2024
handshake
Cell Therapies
Elevating the CGT Manufacturing Game: How Outsourcing Enables Success
Elevating the CGT Manufacturing Game: How Outsourcing Enables Success
by
Omkar Kawalekar,
Audrey Greenberg
and 1 more
Jun 12, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Global Markets
US Speaker vows Congress will vote on BIOSECURE in 2024
US Speaker vows Congress will vote on BIOSECURE in 2024
by
Richard Daverman
Jul 15, 2024
2 Min Read
thumbnail
Deal Making
Nona teams with Alaya.bio to advance CAR-T therapies
Nona teams with Alaya.bio to advance CAR-T therapies
by
Shreeyashi Ojha
Jul 15, 2024
2 Min Read
Home
Bioprocess Insider
Deal-Making
Deal-Making
Zolgensma approval marks success for REGENXBIO’s vector platform
Therapeutic Class
Zolgensma approval marks success for REGENXBIO’s vector platform
Zolgensma approval marks success for REGENXBIO’s vector platform
by
Dan Stanton
May 29, 2019
|
2 Min Read
Novartis to end $300m a year facility services deal with ISS
Deal Making
Novartis to end $300m a year facility services deal with ISS
Novartis to end $300m a year facility services deal with ISS
by
BPI Staff
May 28, 2019
1 Min Read
ProBioGen licenses duck cell line tech to Vaccitech for viral vaccines
Bioprocess Insider
ProBioGen licenses duck cell line tech to Vaccitech for viral vaccines
ProBioGen licenses duck cell line tech to Vaccitech for viral vaccines
by
Dan Stanton
May 24, 2019
2 Min Read
WuXi scouts single-use site for Chinese vaccine joint venture
Global Markets
WuXi scouts single-use site for Chinese vaccine joint venture
WuXi scouts single-use site for Chinese vaccine joint venture
by
Dan Stanton
May 22, 2019
2 Min Read
Evotec lays down $90m to buy Just for kickstarting biologics biz
Deal Making
Evotec lays down $90m to buy Just for kickstarting biologics biz
Evotec lays down $90m to buy Just for kickstarting biologics biz
by
BPI Staff
May 21, 2019
2 Min Read
Cryoport acquires Cryogene for $20.5m, adds Texas biostorage site
Deal Making
Cryoport acquires Cryogene for $20.5m, adds Texas biostorage site
Cryoport acquires Cryogene for $20.5m, adds Texas biostorage site
by
Dan Stanton
May 17, 2019
2 Min Read
Deal Making
CDMO round-up: News from Patheon, Samsung and Sekisui
CDMO round-up: News from Patheon, Samsung and Sekisui
May 15, 2019
|
3 Min Read
by
BPI Staff
Deal Making
Fungal infection? Biopharma embrace boosts Dyadic’s high titer platform
Fungal infection? Biopharma embrace boosts Dyadic’s high titer platform
May 15, 2019
|
3 Min Read
by
Dan Stanton
Global Markets
Subcutaneous success a boon for Halozyme, but biosimilars hit royalties
Subcutaneous success a boon for Halozyme, but biosimilars hit royalties
May 10, 2019
|
3 Min Read
by
Dan Stanton
Deal Making
Bayer plans $150m Californian biologics plant, creating 100 jobs
Bayer plans $150m Californian biologics plant, creating 100 jobs
May 10, 2019
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Alnylam: ‘Onpattro will springboard us into a global biopharma firm’
Alnylam: ‘Onpattro will springboard us into a global biopharma firm’
May 7, 2019
|
2 Min Read
by
Dan Stanton
Deal Making
Alector inks strategic deal with Lonza for early-phase candidates
Alector inks strategic deal with Lonza for early-phase candidates
May 6, 2019
|
2 Min Read
by
Dan Stanton
Upstream & Downstream Processing
Repligen to buy analytics firm C Technologies for $240m
Repligen to buy analytics firm C Technologies for $240m
May 3, 2019
|
3 Min Read
by
Dan Stanton
Deal Making
PureTech cites Big Pharma tech partnerships as 2018 highlights
PureTech cites Big Pharma tech partnerships as 2018 highlights
May 1, 2019
|
2 Min Read
by
Gareth Macdonald
Therapeutic Class
Lilly inks potential $440m antibody oligo conjugate deal
Lilly inks potential $440m antibody oligo conjugate deal
Apr 26, 2019
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Thermo Fisher allots $125m to expand CDMO buy Brammer
Thermo Fisher allots $125m to expand CDMO buy Brammer
Apr 26, 2019
|
3 Min Read
by
Dan Stanton
Deal Making
Emerson buys Bio-G, adding modeling and scheduling software
Emerson buys Bio-G, adding modeling and scheduling software
Apr 24, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
Catalent’s Paragon plans second plant to support Sarepta pipeline
Catalent’s Paragon plans second plant to support Sarepta pipeline
Apr 19, 2019
|
2 Min Read
by
BPI Staff
Therapeutic Class
Allele SCM partnership looks to stem cells to treat diabetes
Allele SCM partnership looks to stem cells to treat diabetes
Apr 18, 2019
|
2 Min Read
by
Dan Stanton
Upstream & Downstream Processing
CRISPR consortium launched to improve CHO cell lines
CRISPR consortium launched to improve CHO cell lines
Apr 17, 2019
|
3 Min Read
by
Dan Stanton
Deal Making
Catalent jumps into 'transformative' gene therapy space with $1.2bn Paragon buy
Catalent jumps into 'transformative' gene therapy space with $1.2bn Paragon buy
Apr 15, 2019
|
2 Min Read
by
Dan Stanton
Upstream & Downstream Processing
ChromaCon buy and expansions tip YMC further into the biologics space
ChromaCon buy and expansions tip YMC further into the biologics space
Apr 10, 2019
|
2 Min Read
by
Dan Stanton
Deal Making
RNAi: Regeneron pumps $800m into ‘potentially game-changing science’
RNAi: Regeneron pumps $800m into ‘potentially game-changing science’
Apr 9, 2019
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Lonza goes live with microbiome CMO joint venture
Lonza goes live with microbiome CMO joint venture
Apr 9, 2019
|
2 Min Read
by
Gareth Macdonald
Facilities & Capacity
Sangamo ‘excited’ about Thermo’s takeover of CDMO partner Brammer
Sangamo ‘excited’ about Thermo’s takeover of CDMO partner Brammer
Apr 8, 2019
|
2 Min Read
by
Dan Stanton